- Global Pharma News & Resources

Stem Cells Market to be Worth US$270.5 Billion by 2025; Burgeoning Demand for Regenerative Therapies to Drive Market, Says TMR

Stem Cells Market to be Worth US$270.5 Billion by 2025; Burgeoning Demand for Regenerative Therapies to Drive Market, Says TMR

PR Newswire

ALBANY, New York, September 27, 2018

ALBANY, New York, September 27, 2018 /PRNewswire/ --

The global stem cells market is anticipated to witness swift growth in the forthcoming years, according to report published by Transparency Market Research (TMR). The competitive ecosystem of the global stem cells market is expected to witness a competitive streak among the vendors. The key strategy adopted by companies in the market is expansion via multidisciplinary and multi-sector collaborations. This is carried out in order to produce high quality pluripotent and differentiated cells on a large scale. The market vendors are expected to have an innovative product portfolio is predicted to drive competition in the market, consequently leading to growth. Another pivotal policy utilized by players in the global stem cell market is to amass investments from international organizations. Vendors are also seen fostering collaborations and partnerships with several pharmaceutical enterprises in order to leave a footprint in the industry.

     (Logo: )

Prominent vendors operating in the global stem cells market are U.S. Stem Cell, Inc., Cellular Engineering Technologies Inc., Osiris Therapeutics, Inc., Takara Bio Inc., and Astellas Pharma Inc., among several others.

Get PDF Brochure for Research Insights at:

According to TMR's analysts, the global stem cells market is anticipated to rise at a CAGR of 13.8% during the period from 2017 to 2025 to become worth US$270.5 bn by 2025.

Growing Awareness of Novel Therapies to Drive Growth

Bone marrow is the most popular innovation for cell securing attributable to the way that generation of new cells from bone marrow stem cells is generally quicker. Additionally, bone marrow began cells are similarly more focused than from different locales. Cell procurement innovation is assessed to represent a significant share and is required to keep up this situation all through the forthcoming years. Developing mindfulness about their criticalness has prompted noteworthy development in cell reaping, which thus, has added to its substantial offer.

Browse Research Release at

Additionally, cellular treatments are perceived as the following significant progressions in health care policies. Firms are growing their cellular treatment portfolio, understanding the future capability of this field in the treatment of Parkinson's infection, type 1 diabetes, spinal line damage, Alzheimer's ailment, and others. Researchers are occupied with finding novel techniques to make adult stem cells. This is to address the expanding interest for stem cell generation for potential examination in disease management. This factor is surely anticipated that would quicken the advance of regenerative solutions, subsequently driving the growth of the global stem cell market.

Request a Sample of Report:

Regenerative Medicines to Offer Rich Market Opportunity

Regenerative drugs are seen to hold the potential for conceiving early-mediation medications to fix degenerative sicknesses and awful damage. Besides, this accessibility of the approach crosswise over extensive variety of clinical zones is driving the segment.

Stem cells are perceived to hold opportunities for pharmaceutical organizations by propelling the ID of lead competitors and empowering firms to create novel medications. Also, stem cell-based inquires about have propelled single-cell investigation which additionally helps in examining drug impacts on cell separation. Furthermore, developing dependence of medication creating elements on cellular systems is foreseen to help this portion in making progress in future market.

Request For Discount On This Report:

Security and moral issues are a factor that could hinder the global stem cell market's growth. Security issues concerning stem cells put away in banks should be routed to completely abuse the gigantic capability of stem cell treatment. The utilization of embryonic stem cells fundamentally includes the pulverization of the blastocyst and is therefore viewed as an infringement of human rights by the individuals who trust that the fetus holds the privilege to live.

Browse More Healthcare Market Research Reports

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453


Research Blog:

Editor Details

Last Updated: 27-Sep-2018